Risk for venous thromboembolism in transgender patients undergoing cross-sex hormone treatment: a systematic review

VS Kotamarti, N Greige, AJ Heiman… - The journal of sexual …, 2021 - academic.oup.com
Background Feminizing and masculinizing hormone treatments are established components
of management in transgender patients. Exogenous hormones have been associated with …

Hormone replacement therapy in women with history of thrombosis or a thrombophilia

G Morris, V Talaulikar - Post Reproductive Health, 2023 - journals.sagepub.com
Findings from the Women's Health Initiative (WHI) randomised placebo-controlled trial (RCT)
were published at the beginning of this century. They suggested that hormone replacement …

[HTML][HTML] Restoration of serum estradiol and reduced incidence of miscarriage in patients with low serum estradiol during pregnancy: a retrospective cohort study using …

P Boyle, K Andralojc, S van der Velden… - … in Reproductive Health, 2024 - frontiersin.org
Background Low serum estradiol in early pregnancy is associated with an elevated risk of
miscarriage. We sought to determine whether efforts to restore low blood estradiol via …

Isopsoralen promotes osteogenic differentiation of human jawbone marrow mesenchymal cells through Notch signaling pathway

Z Zhu, Z Wang, C Ma, J Zhou, W Zhang - Annals of Anatomy-Anatomischer …, 2023 - Elsevier
Background The aim of this study was to investigate the effect of isopsoralen on osteogenic
differentiation of human jawbone marrow mesenchymal cells and its possible mechanism …

[HTML][HTML] Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary …

NA Tritos, PK Fazeli, A McCormack, SM Mallea-Gil… - Pituitary, 2022 - Springer
Purpose In adults and children, transsphenoidal surgery (TSS) represents the cornerstone of
management for most large or functioning sellar lesions with the exception of prolactinomas …

Estradiol-responsive miR-365a-3p interacts with tissue factor 3′ UTR to modulate tissue factor-initiated thrombin generation

J Tian, MJ Adams, JWT Tay, I James… - Thrombosis and …, 2021 - thieme-connect.com
Background High estradiol (E 2) levels are linked to an increased risk of venous
thromboembolism; however, the underlying molecular mechanism (s) remain poorly …

Consensus-led recommendations supporting choice and personalisation of hormone replacement therapy in menopause care

P Briggs, K Barber, K Cooke, T Hillard… - Post Reproductive …, 2022 - journals.sagepub.com
Objective Inequity of access and choice to different hormone replacement therapy (HRT)
products across the UK has been suggested (Hillman, 2020). While, the cause is not entirely …

[HTML][HTML] Venous thromboembolism in autologous blood or marrow transplantation survivors: a report from the blood or marrow transplant survivor study

R Gangaraju, Y Chen, L Hageman, J Wu… - Biology of Blood and …, 2019 - Elsevier
Hemostatic complications are commonly encountered in blood or marrow transplantation
(BMT) recipients, increasing their morbidity and mortality and are well described in the …

Continuous oral contraceptives versus long-term pituitary desensitization prior to IVF/ICSI in moderate to severe endometriosis: study protocol of a non-inferiority …

LEE Van der Houwen, MCI Lier… - Human …, 2019 - academic.oup.com
STUDY QUESTIONS The primary objective is to investigate if continuous use of oral
contraceptives is non-inferior compared to long-term pituitary desensitization with a GnRH …

Understanding patient assessment and treatment in deep vein thrombosis.

S Duffy - Nursing Standard (Royal College of Nursing (Great …, 2022 - europepmc.org
Deep vein thrombosis (DVT) commonly develops in the deep veins of the legs, but it can
potentially form in any part of the body. There are several risk factors associated with DVT …